Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ...

The hospital failed to identify the patient as at-risk for a serious blot clot condition before discharging her, state ...

Doug Koke died on Dec. 31 at age 73. He was a local businessowner and shaped the Oregon Harley-Davidson ride-in tradition for ...

CPT I code for NanoKnife prostate procedures is set to take effect on January 1, with management expecting incremental, ...

Nordic women with PCOS face a higher risk for cardiovascular disease than those without, with the risk persisting in those ...

Researchers have found in a new study that adults with type 2 diabetes and cancer who used GLP-1 receptor agonists had a ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

Airlines are not required to tell passengers how much legroom they'll be getting when booking a flight, raising safety and ...

The Penang High Court enters consent judgment following settlement of the civil suit reached with the government without ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...